Is increasing pretreatment HIV drug resistance a real menace or minor detail? - Authors' reply

Affiliations

¹ Department of Global Health, University of Washington, Seattle, WA, USA.
² Center for Global Infectious Diseases Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
³ Center for Global Infectious Diseases Research, Seattle Children's Research Institute, Seattle, WA 98109, USA; Department of Laboratory Medicine and Department of Paediatrics, University of Washington, Seattle, WA, USA. Electronic address: lfrenkel@u.washington.edu.

Comment

Michael H Chung et al. Lancet HIV. 2020 May.

. 2020 May;7(5):e317-e318.

doi: 10.1016/S2352-3018(20)30049-7.

¹ Department of Global Health, University of Washington, Seattle, WA, USA.
² Center for Global Infectious Diseases Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
³ Center for Global Infectious Diseases Research, Seattle Children's Research Institute, Seattle, WA 98109, USA; Department of Laboratory Medicine and Department of Paediatrics, University of Washington, Seattle, WA, USA. Electronic address: lfrenkel@u.washington.edu.

No abstract available

Comment on

Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial.
Derache A, Iwuji CC, Baisley K, Danaviah S, Marcelin AG, Calvez V, de Oliveira T, Dabis F, Porter K, Pillay D. Derache A, et al. Clin Infect Dis. 2019 Jul 2;69(2):207-214. doi: 10.1093/cid/ciy881. Clin Infect Dis. 2019. PMID: 30321314 Free PMC article.
Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial.
Chung MH, McGrath CJ, Beck IA, Levine M, Milne RS, So I, Andersen N, Dross S, Coombs RW, Chohan B, Yatich N, Kiptinness C, Sakr SR, Kiarie JN, Frenkel LM. Chung MH, et al. Lancet HIV. 2020 Feb;7(2):e104-e112. doi: 10.1016/S2352-3018(19)30337-6. Epub 2019 Dec 7. Lancet HIV. 2020. PMID: 31818716 Free PMC article. Clinical Trial.
Is increasing pretreatment HIV drug resistance a real menace or minor detail?
Inzaule SC, Hamers RL, Bertagnolio S. Inzaule SC, et al. Lancet HIV. 2020 May;7(5):e316-e317. doi: 10.1016/S2352-3018(20)30048-5. Lancet HIV. 2020. PMID: 32386718 No abstract available.